Back to Trades
Other3
Denali Therapeutics Inc.
DNLI
Total Value
$NaN
Company Information
- Company Name
- Denali Therapeutics Inc.
- Ticker Symbol
- DNLI
- CIK
- 0001714899
Insider Information
- Name
- Chin Peter Scott
- Role
- Chief Medical Officer
- Location
- SOUTH SAN FRANCISCO, CA
Officer
Filing Details
- Filing Date
- Apr 20, 2026
- Transaction Date
- Apr 10, 2026
- Accession Number
- 0001714899-26-000049
- Form Type
- 3
Footnotes
- (F1)Includes 2,326 shares acquired under the Denali ESPP.
- (F2)Includes 145,845 Unvested RSU's.
- (F3)The shares subject to the option are fully vested and exercisable.
- (F4)25% of the shares subject to the option vested on January 3, 2024 and an additional 1/48 of the shares vested monthly thereafter.
- (F5)25% of the shares subject to the option vested on January 3, 2025 and an additional 1/48 of the shares vest monthly thereafter.
- (F6)25% of the shares subject to the option vested on January 3, 2026 and an additional 1/48 of the shares vest monthly thereafter.
- (F7)25% of the shares subject to the option will vest on January 3, 2027 and an additional 1/48 of the shares vest monthly thereafter.